Cargando…
Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome
Alpha mannose-oligosaccharide (MOS) prebiotics are widely deployed in animal agriculture as immunomodulators as well as to enhance growth and gut health. Their mode of action is thought to be mediated through their impact on host microbial communities and their associated metabolism. Bio-Mos is a co...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241627/ https://www.ncbi.nlm.nih.gov/pubmed/35532227 http://dx.doi.org/10.1128/spectrum.01953-21 |
_version_ | 1784737847876517888 |
---|---|
author | Kazlauskaite, Raminta Cheaib, Bachar Humble, Joseph Heys, Chloe Ijaz, Umer Zeeshan Connelly, Stephanie Sloan, William T. Russell, Julie Martinez-Rubio, Laura Sweetman, John Kitts, Alex McGinnity, Philip Lyons, Philip Llewellyn, Martin S. |
author_facet | Kazlauskaite, Raminta Cheaib, Bachar Humble, Joseph Heys, Chloe Ijaz, Umer Zeeshan Connelly, Stephanie Sloan, William T. Russell, Julie Martinez-Rubio, Laura Sweetman, John Kitts, Alex McGinnity, Philip Lyons, Philip Llewellyn, Martin S. |
author_sort | Kazlauskaite, Raminta |
collection | PubMed |
description | Alpha mannose-oligosaccharide (MOS) prebiotics are widely deployed in animal agriculture as immunomodulators as well as to enhance growth and gut health. Their mode of action is thought to be mediated through their impact on host microbial communities and their associated metabolism. Bio-Mos is a commercially available prebiotic currently used in the agri-feed industry, but studies show contrasting results of its effect on fish performance and feed efficiency. Thus, detailed studies are needed to investigate the effect of MOS supplements on the fish microbiome to enhance our understanding of the link between MOS and gut health. To assess Bio-Mos for potential use as a prebiotic growth promoter in salmonid aquaculture, we have modified an established Atlantic salmon in vitro gut model, SalmoSim, to evaluate its impact on the host microbial communities. The microbial communities obtained from ceca compartments from four adult farmed salmon were inoculated in biological triplicate reactors in SalmoSim. Prebiotic treatment was supplemented for 20 days, followed by a 6-day washout period. Inclusion of Bio-Mos in the media resulted in a significant increase in formate (P = 0.001), propionate (P = 0.037) and 3-methyl butanoic acid (P = 0.024) levels, correlated with increased abundances of several, principally, anaerobic microbial genera (Fusobacterium, Agarivorans, Pseudoalteromonas). DNA metabarcoding with the 16S rDNA marker confirmed a significant shift in microbial community composition in response to Bio-Mos supplementation with observed increase in lactic acid producing Carnobacterium. In conjunction with previous in vivo studies linking enhanced volatile fatty acid production alongside MOS supplementation to host growth and performance, our data suggest that Bio-Mos may be of value in salmonid production. Furthermore, our data highlights the potential role of in vitro gut models to complementin vivo trials of microbiome modulators. IMPORTANCE In this paper we report the results of the impact of a prebiotic (alpha-MOS supplementation) on microbial communities, using an in vitro simulator of the gut microbial environment of the Atlantic salmon. Our data suggest that Bio-Mos may be of value in salmonid production as it enhances volatile fatty acid production by the microbiota from salmon pyloric ceca and correlates with a significant shift in microbial community composition with observed increase in lactic acid producing Carnobacterium. In conjunction with previous in vivo studies linking enhanced volatile fatty acid production alongside MOS supplementation to host growth and performance, our data suggest that Bio-Mos may be of value in salmonid production. Furthermore, our data highlights the potential role of in vitro gut models to augment in vivo trials of microbiome modulators. |
format | Online Article Text |
id | pubmed-9241627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-92416272022-06-30 Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome Kazlauskaite, Raminta Cheaib, Bachar Humble, Joseph Heys, Chloe Ijaz, Umer Zeeshan Connelly, Stephanie Sloan, William T. Russell, Julie Martinez-Rubio, Laura Sweetman, John Kitts, Alex McGinnity, Philip Lyons, Philip Llewellyn, Martin S. Microbiol Spectr Research Article Alpha mannose-oligosaccharide (MOS) prebiotics are widely deployed in animal agriculture as immunomodulators as well as to enhance growth and gut health. Their mode of action is thought to be mediated through their impact on host microbial communities and their associated metabolism. Bio-Mos is a commercially available prebiotic currently used in the agri-feed industry, but studies show contrasting results of its effect on fish performance and feed efficiency. Thus, detailed studies are needed to investigate the effect of MOS supplements on the fish microbiome to enhance our understanding of the link between MOS and gut health. To assess Bio-Mos for potential use as a prebiotic growth promoter in salmonid aquaculture, we have modified an established Atlantic salmon in vitro gut model, SalmoSim, to evaluate its impact on the host microbial communities. The microbial communities obtained from ceca compartments from four adult farmed salmon were inoculated in biological triplicate reactors in SalmoSim. Prebiotic treatment was supplemented for 20 days, followed by a 6-day washout period. Inclusion of Bio-Mos in the media resulted in a significant increase in formate (P = 0.001), propionate (P = 0.037) and 3-methyl butanoic acid (P = 0.024) levels, correlated with increased abundances of several, principally, anaerobic microbial genera (Fusobacterium, Agarivorans, Pseudoalteromonas). DNA metabarcoding with the 16S rDNA marker confirmed a significant shift in microbial community composition in response to Bio-Mos supplementation with observed increase in lactic acid producing Carnobacterium. In conjunction with previous in vivo studies linking enhanced volatile fatty acid production alongside MOS supplementation to host growth and performance, our data suggest that Bio-Mos may be of value in salmonid production. Furthermore, our data highlights the potential role of in vitro gut models to complementin vivo trials of microbiome modulators. IMPORTANCE In this paper we report the results of the impact of a prebiotic (alpha-MOS supplementation) on microbial communities, using an in vitro simulator of the gut microbial environment of the Atlantic salmon. Our data suggest that Bio-Mos may be of value in salmonid production as it enhances volatile fatty acid production by the microbiota from salmon pyloric ceca and correlates with a significant shift in microbial community composition with observed increase in lactic acid producing Carnobacterium. In conjunction with previous in vivo studies linking enhanced volatile fatty acid production alongside MOS supplementation to host growth and performance, our data suggest that Bio-Mos may be of value in salmonid production. Furthermore, our data highlights the potential role of in vitro gut models to augment in vivo trials of microbiome modulators. American Society for Microbiology 2022-05-09 /pmc/articles/PMC9241627/ /pubmed/35532227 http://dx.doi.org/10.1128/spectrum.01953-21 Text en Copyright © 2022 Kazlauskaite et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Kazlauskaite, Raminta Cheaib, Bachar Humble, Joseph Heys, Chloe Ijaz, Umer Zeeshan Connelly, Stephanie Sloan, William T. Russell, Julie Martinez-Rubio, Laura Sweetman, John Kitts, Alex McGinnity, Philip Lyons, Philip Llewellyn, Martin S. Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome |
title | Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome |
title_full | Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome |
title_fullStr | Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome |
title_full_unstemmed | Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome |
title_short | Deploying an In Vitro Gut Model to Assay the Impact of the Mannan-Oligosaccharide Prebiotic Bio-Mos on the Atlantic Salmon (Salmo salar) Gut Microbiome |
title_sort | deploying an in vitro gut model to assay the impact of the mannan-oligosaccharide prebiotic bio-mos on the atlantic salmon (salmo salar) gut microbiome |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241627/ https://www.ncbi.nlm.nih.gov/pubmed/35532227 http://dx.doi.org/10.1128/spectrum.01953-21 |
work_keys_str_mv | AT kazlauskaiteraminta deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome AT cheaibbachar deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome AT humblejoseph deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome AT heyschloe deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome AT ijazumerzeeshan deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome AT connellystephanie deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome AT sloanwilliamt deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome AT russelljulie deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome AT martinezrubiolaura deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome AT sweetmanjohn deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome AT kittsalex deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome AT mcginnityphilip deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome AT lyonsphilip deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome AT llewellynmartins deployinganinvitrogutmodeltoassaytheimpactofthemannanoligosaccharideprebioticbiomosontheatlanticsalmonsalmosalargutmicrobiome |